{{Rsnum
|rsid=3181052
|Gene=IL1RN
|Chromosome=2
|position=113128472
|Orientation=plus
|GMAF=0.2718
|Gene_s=IL1RN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 21.2 | 77.0
| HCB | 34.8 | 45.9 | 19.3
| JPT | 31.9 | 54.9 | 13.3
| YRI | 2.0 | 37.4 | 60.5
| ASW | 0.0 | 26.3 | 73.7
| CHB | 34.8 | 45.9 | 19.3
| CHD | 32.4 | 51.9 | 15.7
| GIH | 2.0 | 18.0 | 80.0
| LWK | 4.5 | 30.9 | 64.5
| MEX | 1.8 | 24.6 | 73.7
| MKK | 1.3 | 27.3 | 71.4
| TSI | 1.0 | 19.8 | 79.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=23602982
|Title=IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}